Romosozumab plus denosumab for postmenopausal osteoporosis with fractures
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests whether a combination of two medications, romosozumab and denosumab, can improve bone strength better than standard care for women after menopause who have osteoporosis and have had multiple fractures. The goal is to see if this combined approach reduces the risk of future breaks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has gone through menopause.
- You have been diagnosed with osteoporosis (weakened bones).
- You are between 55 and 85 years old.
- You have had more than one fracture due to weak bones (fragility fractures).
- You have not had a stroke, heart attack, or serious kidney problems, and you are not allergic to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatment plans for women with osteoporosis to see which one improves hip bone density more. Participants will either get two medications in sequence (romosozumab followed by denosumab) or one medication (zoledronic acid), both given as injections or infusions. The goal is to find a treatment that reduces fracture risk.
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
This study tests a combination of two bone-building drugs (romosozumab and teriparatide) in postmenopausal women with osteoporosis who are at high risk for fractures. The goal is to see if the combination strengthens bones faster and better than either drug alone.
This trial is testing a medicine called romosozumab to treat postmenopausal women with severe osteoporosis and a recent fracture. It aims to find the best way to use this drug to strengthen bones and prevent more fractures.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study looks at what changes in the body after starting romosozumab (an osteoporosis treatment) in postmenopausal women at higher risk for fractures. Researchers want to understand the treatment’s “mechanism,” which may help improve future osteoporosis care.
Hear when a new Osteoporosis in Post-menopausal Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.